Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		01343naa a2200313 4500
001		oai:prod.swepub.kib.ki.se:144436173
003		SwePub
008		240913s2020 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1444361732 URI
024	7	a https://doi.org/10.1097/GME.00000000000014972 DOI
040		a (SwePub)ki
041		a eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Hirschberg, ALu Karolinska Institutet4 aut
245	1 0	a Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial
264	1	c 2020
700	1	a Sanchez-Rovira, P4 aut
700	1	a Presa-Lorite, J4 aut
700	1	a Campos-Delgado, M4 aut
700	1	a Gil-Gil, M4 aut
700	1	a Lidbrink, E4 aut
700	1	a Suarez-Almarza, J4 aut
700	1	a Nieto-Magro, C4 aut
710	2	a Karolinska Institutet4 org
773	0	t Menopause (New York, N.Y.)g 27:5, s. 526-534q 27:5<526-534x 1530-0374
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:144436173
856	4 8	u https://doi.org/10.1097/GME.0000000000001497

Av författaren/redakt...: Hirschberg, AL; Sanchez-Rovira, ...; Presa-Lorite, J; Campos-Delgado, ...; Gil-Gil, M; Lidbrink, E; visa fler...; Suarez-Almarza, ...; Nieto-Magro, C; visa färre...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.